Variability in the efficacy of a standardized antenatal steroid treatment was independent of maternal or fetal plasma drug levels: evidence from a sheep model of pregnancy
- 20 May 2020
- journal article
- research article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 223 (6), 921.e1-921.e10
- https://doi.org/10.1016/j.ajog.2020.05.032
Abstract
No abstract availableFunding Information
- Channel 7 Telethon Trust
- Bill and Melinda Gates Foundation
This publication has 22 references indexed in Scilit:
- The timing of administration of antenatal corticosteroids in women with indicated preterm birthAmerican Journal of Obstetrics and Gynecology, 2015
- Effect of Antenatal Corticosteroids on Fetal Growth and Gestational Age at BirthObstetrics & Gynecology, 2012
- PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft ExcelComputer Methods and Programs in Biomedicine, 2010
- The “Vitamin D Council” advertisementAmerican Journal of Obstetrics and Gynecology, 2009
- Impact of a ‘rescue course’ of antenatal corticosteroids: a multicenter randomized placebo-controlled trialAmerican Journal of Obstetrics and Gynecology, 2009
- The role of the protein-binding on the mode of drug action as well the interactions with other drugsEuropean Journal of Drug Metabolism and Pharmacokinetics, 2008
- Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trialThe Lancet, 2008
- Scientific basis and therapeutic regimens for use of antenatal glucocorticoidsAmerican Journal of Obstetrics and Gynecology, 1995
- The Significance of Plasma Protein Binding on the Fetal/Maternal Distribution of Drugs at Steady-StateClinical Pharmacokinetics, 1988
- Lung Surfactant Replacement in Premature Lambs with Extracted Lipids from Bovine Lung Lavage: Effects of Dose, Dispersion Technique, and Gestational AgePediatric Research, 1985